Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Your filters
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study.
Publication Type: Academic Journal
Source(s): Lancet Respiratory Medicine; Jul2022, Vol. 10 Issue 7, p689-699, 11p
Abstract: Copyright of Lancet Respiratory Medicine is the property of Lancet and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or ...
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Publication Type: Academic Journal
Source(s): Lancet. 4/2/2022, Vol. 399 Issue 10332, p1303-1312. 10p.
Abstract: Background: The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility, with early studies indicating lower severity of infection than that of the delta variant (B.1.617.2). We aimed to better charac...
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.
Publication Type: Academic Journal
Source(s): Lancet Respiratory Medicine; Dec2022, Vol. 10 Issue 12, p1129-1136, 8p
Abstract: Copyright of Lancet Respiratory Medicine is the property of Lancet and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or ...
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
Publication Type: Academic Journal
Source(s): Lancet. Mar2023, Vol. 401 Issue 10379, p833-842. 10p.
Abstract: Understanding the level and characteristics of protection from past SARS-CoV-2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe disease is essential for predicting future potential disease burden, for designing polici...
Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants.
Publication Type: Academic Journal
Source(s): Lancet Respiratory Medicine; Jul2022, Vol. 10 Issue 7, pe61-e62, 2p
Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
Publication Type: Academic Journal
Source(s): Lancet. Feb2023, Vol. 401 Issue 10375, p447-457. 11p.
Abstract: In 2021, we showed an increased risk associated with COVID-19 in pregnancy. Since then, the SARS-CoV-2 virus has undergone genetic mutations. We aimed to examine the effects on maternal and perinatal outcomes of COVID-19 during pregnancy, and evaluate ...
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022.
Publication Type: Academic Journal
Source(s): Lancet Respiratory Medicine; May2023, Vol. 11 Issue 5, p439-452, 14p
Abstract: Copyright of Lancet Respiratory Medicine is the property of Lancet and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or ...
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study.
Publication Type: Academic Journal
Source(s): Lancet Respiratory Medicine; Feb2023, Vol. 11 Issue 2, p176-187, 12p
Abstract: Copyright of Lancet Respiratory Medicine is the property of Lancet and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or ...
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study.
Publication Type: Academic Journal
Source(s): Lancet Respiratory Medicine; Jun2022, Vol. 10 Issue 6, p566-572, 7p
Abstract: Copyright of Lancet Respiratory Medicine is the property of Lancet and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or ...
SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys.
Publication Type: Academic Journal
Source(s): Lancet Respiratory Medicine; Apr2022, Vol. 10 Issue 4, p355-366, 12p
Abstract: Copyright of Lancet Respiratory Medicine is the property of Lancet and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or ...